Enzon Pharmaceuticals, Inc. (ENZN)
OTCMKTS: ENZN · Delayed Price · USD
0.145
+0.015 (11.54%)
May 24, 2024, 9:30 AM EDT - Market closed

Enzon Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 1983
Revenue
00.030.70.050.21
Upgrade
Revenue Growth (YoY)
--96.29%1248.08%-74.88%-97.01%
Upgrade
Gross Profit
00.030.70.050.21
Upgrade
Selling, General & Admin
1.041.061.171.361.18
Upgrade
Other Operating Expenses
00.650.0100
Upgrade
Operating Expenses
1.041.061.171.361.18
Upgrade
Operating Income
-1.04-1.03-0.47-1.31-0.97
Upgrade
Interest Income
2.260.650.0100
Upgrade
Interest Expense
0-0.65000
Upgrade
Other Expense / Income
-0.65--0-
Upgrade
Pretax Income
1.22-0.39-0.46-1.3-0.97
Upgrade
Income Tax
-0.16-0.20.010.010.01
Upgrade
Net Income
1.37-0.19-0.47-1.31-0.98
Upgrade
Shares Outstanding (Basic)
7474745144
Upgrade
Shares Outstanding (Diluted)
7474745144
Upgrade
Shares Change
--45.23%15.57%-
Upgrade
EPS (Basic)
0.02-0.00-0.01-0.03-0.02
Upgrade
EPS (Diluted)
0.02-0.00-0.01-0.03-0.02
Upgrade
Free Cash Flow
1.31-0.66-0.5-0.386.91
Upgrade
Free Cash Flow Per Share
0.02-0.01-0.01-0.010.16
Upgrade
Gross Margin
-100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
--3969.23%-66.90%-2509.62%-470.05%
Upgrade
Profit Margin
--715.38%-66.90%-2521.15%-472.95%
Upgrade
Free Cash Flow Margin
--2534.62%-71.47%-730.77%3335.75%
Upgrade
Effective Tax Rate
-12.82%----
Upgrade
EBITDA
-1.04-1.03-0.47-1.31-0.97
Upgrade
EBITDA Margin
--3969.23%-66.90%-2509.62%-470.05%
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.